Suchergebnisse - "Mallen, Christian"

PubPharm (632)

361

Incident acute pseudogout and prior bisphosphonate use : Matched case-control study in the UK-Clinical Practice Research Datalink

enthalten in: Medicine | 2017

von Roddy, E. | Muller, S. | Paskins, Z. | +3

362

Qualitative Exploration of Illness Perceptions of Rheumatoid Arthritis in the General Public

enthalten in: Musculoskeletal care | 2017

von Simons, G. | Mason, A. | Falahee, M. | +4

363

Colchicine in overdose

enthalten in: The British journal of general practice : the journal of the Royal College of General Practitioners | 2017

von Roddy, E. | Mallen, C.

CommentOn: Br J Gen Pract. 2016 Dec;66(653):605. - PMID 27884896

364

Prognosis research ideally should measure time-varying predictors at their intended moment of use

enthalten in: Diagnostic and prognostic research | 2017

von Whittle, R. | Royle, K. | Jordan, K. | +3

365

Patients' views on the causes of their polymyalgia rheumatica : a content analysis of data from the PMR Cohort Study

enthalten in: BMJ open | 2017

von Tshimologo, M. | Saunders, B. | Muller, S. | +2

366

Possible giant cell arteritis symptoms are common in newly diagnosed patients with Polymyalgia Rheumatica : results from an incident primary care PMR cohort

enthalten in: BMC rheumatology | 2017

von Masson, W. | Muller, S. | Whittle, R. | +4

367

Generic prognostic factors for musculoskeletal pain in primary care : a systematic review

enthalten in: BMJ open | 2017

von Artus, M. | Campbell, P. | Mallen, C. | +2

368

Prognosis research ideally should measure time-varying predictors at their intended moment of use

enthalten in: Diagnostic and prognostic research | 2017

von Whittle, R. | Royle, K. | Jordan, K. | +3

369

Rheumatoid arthritis is getting less frequent—results of a nationwide population-based cohort study

enthalten in: Rheumatology | 2017

von Abhishek, A. | Doherty, M. | Kuo, C. | +3

370

Colchicine in overdose

enthalten in: British journal of general practice | 2017

von Roddy, E. | Mallen, C.